GA
Geneva Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.82M | Sell |
5,735
-72
| -1% | -$35.4K | 0.05% | 164 |
|
|
2017
Q1 | $2.25M | Sell |
5,807
-863
| -13% | -$334K | 0.04% | 193 |
|
|
2016
Q4 | $2.45M | Sell |
6,670
-62,736
| -90% | -$23M | 0.05% | 180 |
|
|
2016
Q3 | $27.9M | Sell |
69,406
-180
| -0.3% | -$72.4K | 0.52% | 58 |
|
|
2016
Q2 | $24.3M | Sell |
69,586
-1,216
| -2% | -$425K | 0.48% | 65 |
|
|
2016
Q1 | $25.5M | Sell |
70,802
-78,950
| -53% | -$28.5M | 0.51% | 63 |
|
|
2015
Q4 | $81.3M | Sell |
149,752
-24,005
| -14% | -$13M | 1.56% | 16 |
|
|
2015
Q3 | $80.8M | Buy |
173,757
+12,343
| +8% | +$5.74M | 1.63% | 13 |
|
|
2015
Q2 | $82.3M | Buy |
161,414
+1,179
| +0.7% | +$601K | 1.47% | 18 |
|
|
2015
Q1 | $72.3M | Sell |
160,235
-39,836
| -20% | -$18M | 1.31% | 24 |
|
|
2014
Q4 | $82.1M | Sell |
200,071
-5,573
| -3% | -$2.29M | 1.53% | 15 |
|
|
2014
Q3 | $74.1M | Buy |
205,644
+66,468
| +48% | +$24M | 1.4% | 18 |
|
|
2014
Q2 | $39.3M | Sell |
139,176
-54,958
| -28% | -$15.5M | 0.72% | 55 |
|
|
2014
Q1 | $58.3M | Buy |
194,134
+8,793
| +5% | +$2.64M | 1.07% | 37 |
|
|
2013
Q4 | $51M | Sell |
185,341
-250
| -0.1% | -$68.8K | 0.94% | 41 |
|
|
2013
Q3 | $58.1M | Buy |
+185,591
| New | +$58.1M | 1.21% | 27 |
|